Random Primer Sets to Reduce Chloroplast DNA Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing DNA library preparation methods for genome analysis are inconvenient, lack reproducibility, and fail to effectively reduce amplification of chloroplast genome fragments, leading to increased complexity and cost.

Innovation Solution

A set of random primers is used in a nucleic acid amplification reaction with a regulated concentration, excluding specific sequences to suppress amplification of chloroplast genome fragments, facilitating a highly reproducible DNA library preparation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If random primers are used for DNA library preparation, then the process becomes more convenient and reproducible, but amplification of chloroplast genome fragments increases

Engineering Contradiction:
Improvereproducibility of DNA library preparationVSAvoidamplification of chloroplast genome fragments
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent removes specific primer sequences (TAAGAGACAGTG and TAAGAGACAGTGC) from the random primer set that cause excessive amplification of chloroplast genome fragments. By extracting and eliminating these harmful sequences while retaining other random primers, the method maintains reproducibility while reducing chloroplast amplification interference.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent optimizes the concentration of random primers to 4-200 microM (preferably 4-100 microM) to achieve high reproducibility while minimizing unwanted amplification. This parameter adjustment allows the method to function effectively without requiring nucleotide sequence information, simplifying the process while maintaining quality.

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If AFLP technique is used to reduce genomic complexity, then the complexity of genomic DNA is reduced, but the number of processes and cost increase

Engineering Contradiction:
Improvecomplexity of genomic DNAVSAvoidnumber of processes and cost
Core Design Contradiction:
Device complexityVSEase of manufacture

Solution Approach 1:

The patent eliminates the need for restriction enzyme treatment and adaptor ligation steps by using optimized random primers directly on genomic DNA. This extracts and removes the complex multi-step AFLP procedures while achieving similar genome complexity reduction through selective PCR amplification of genomic regions.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Instead of using restriction enzymes to cut DNA and then ligating adaptors (the conventional AFLP approach), the patent inverts the approach by using random primers to directly amplify genomic DNA regions of interest. This reversal simplifies the workflow while achieving comparable results.

Inventive Principle:
Principle #13The other way round (Inversion)

3Device complexity

If RAPD technique is used for DNA marker analysis, then the process is simplified, but reproducibility of PCR amplification becomes poor

Engineering Contradiction:
Improvesimplicity of PCR processVSAvoidreproducibility of PCR amplification
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent modifies the RAPD technique by changing the primer sequences to exclude TAAGAGACAGTG and TAAGAGACAGTGC, and optimizes primer concentration to 4-200 microM. These parameter changes dramatically improve reproducibility while maintaining the simplicity of the RAPD approach, making it suitable for DNA marker analysis.

Inventive Principle:
Principle #35Parameter changes

4Loss of information

If genomic analysis based on nucleotide sequence analysis is performed, then comprehensive analysis of genetic information is achieved, but the number of processes and cost increase

Engineering Contradiction:
Improvecomprehensive analysis of genetic informationVSAvoidnumber of processes and cost
Core Design Contradiction:
Loss of informationVSEase of manufacture

Solution Approach 1:

The patent uses random primers to amplify representative portions of the genome rather than sequencing the entire genome. This partial action approach provides sufficient genetic information for marker analysis and trait association studies without the excessive cost and complexity of whole-genome sequencing.

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method allows for a highly reproducible and convenient DNA library preparation by significantly reducing amplification of chloroplast genome fragments, thereby simplifying the process and reducing complexity and cost.

Implementation Method 1

conducting a nucleic acid amplification reaction in a reaction solution containing genomic DNA and a random primer selected from the set of random primers at high concentration

Methodology Applied
Scientific EffectPCR amplification:

Implementation Method 2

a set of random primers comprising, as random primers, one or more oligonucleotides selected from among specific sequences

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS12428686B2Set of random primers and method for preparing DNA library using the same
Publication Date: 2025.09.30 TOYOTA JIDOSHA KK
  • US12428686B2 patent drawing
  • US12428686B2 patent drawing
  • US12428686B2 patent drawing

AI summary

When preparing a DNA library via a nucleic acid amplification reaction using a random primer in a convenient and highly reproducible manner, amplification of DNA fragments derived from the chloroplast genome is reduced to a significant extent. A random primer comprises oligonucleotides selected from oligonucleotides group represented by TAAGAGACAGNN excluding those in which 2 bases at the 3′ terminus are TG and oligonucleotides group represented by TAAGAGACAGNNN excluding those in which 3 bases at the 3′ terminus are TGC.